2025 Publication Archive

Health Technology Assessment with Dynamic Prevalence of Disease Over Time

Padula WV, Pontinha VM

Available at SSRN: https://ssrn.com/abstract=5258987 or http://dx.doi.org/10.2139/ssrn.5258987

Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review.

Cheeley MK, Kirkpatrick CF, Brown EE, Dixon DL, Gunter H, Osborn DS, Wilkinson MJ. 

J Clin Lipidol. 2025 May 29:S1933-2874(25)00283-1. doi: 10.1016/j.jacl.2025.05.002.

Impact of pharmacist-physician collaborative care on diabetes quality measure achievement in primary care.

Wagner TD*, Dixon DL, Musselman KT, Shin Y, Dozmorov MG, Musselman KT, Buffington TM, Hyder H, Kirschner B, Jones RM, Salgado TM.

J Manag Care Spec Pharm. 2025;31(6):565-577

Tolerance for chemotherapy-induced peripheral neuropathy among women with metastatic breast cancer: A discrete-choice experiment.

​​Radwan RM*, Schuster A, Hertz DL, Lustberg MB, Vachhani H, Zacholski EH, Sheppard VB, Bridges JFP, Salgado TM.

Breast Cancer Res Treat. 2025;212(1):149-159. doi: 10.1007/s10549-025-07715-5

Factors influencing the decision to discontinue treatment due to chemotherapy-induced peripheral neuropathy among patients with metastatic breast cancer: a best-worst scaling

Rotana M Radwan, John F P Bridges, Daniel L Hertz, Maryam B Lustberg, Hetal Vachhani, Erin Hickey Zacholski, Vanessa B Sheppard, Teresa M Salgado

The case for value-based care in kidney transplantation: insights into geography, growth, and financial models.

Paulus AB, Kumar D, Pontinha VM.

Current Opinion in Organ Transplantation 30(2):p 87-95, April 2025. | DOI: 10.1097/MOT.0000000000001204

Investigating the Time-Varying Nature of Medication Adherence Predictors: An Experimental Approach Using Andersen's Behavioral Model of Health Services Use.

Pontinha VM, Patterson JA, Dixon DL, Carroll NV, Mays D, Farris KB, Holdford DA

Pharmacy (Basel). 2025 Apr 9;13(2):53. doi: 10.3390/pharmacy13020053.

Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes at Cardiology, Endocrinology, and Primary Care Visits

Dixon DL, Salgado TM, Robinson A, Carbone S, Wagner TD, Hyder H, Kirschner B, Musselman KT, Buffington TM, Sabo RT.

Mayo Clin Proc. 2025 Apr;100(4):647-656. doi: 10.1016/j.mayocp.2024.08.026.

Impact of Glucagon-like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients.

Yakubu I*, Spengler J, Taylor P, LaPorte M, Brown A, Sterling S, Agegnehu B, Iaria A, Marks R, Sprague T, Pontinha VM, Patel V, Patidar KR, Siddiqui MS.

Transplantation. 2025 Mar 25. doi: 10.1097/TP.0000000000005361

Characterizing pharmacy deserts and designing a model to minimize inequities in pharmacy distribution in Virginia.

Boyle J, Wittenauer R, Ramella S, Juran C, Bucheit JD, Sisson EM, Kelly Goode JV, Gatewood SS, Salgado TM.

J Am Pharm Assoc (2003). 2025 Mar-Apr;65(2):102334. doi: 10.1016/j.japh.2025.102334.

Modeling Incremental Benefit of Medication Reconciliation on ICU Outcomes

Harris HA, Chan DM, Ellwein Fix L, Chouinard M, Salgado TM, Kang L, Bearman G.

Jt Comm J Qual Patient Saf. 2025;S1553-7250(25)00055-8. doi: 10.1016/j.jcjq.2025.02.001